The short version
At a glance
In the ninth episode of Down To A Science, Kevin G. Libuit talks with Dr. Mark Klein, a diagnostic radiologist and the co-founder and president of ColoWatch, about virtual colonoscopy, also called CT colonography. They discuss why a colon cancer screening test should find polyps as well as cancer, why Dr. Klein believes a test given to healthy people should carry as little risk as possible, how he compares colonoscopy, stool tests and the newer blood tests, what the scan is like for patients, Medicare’s 2025 coverage decision, findings outside the colon, and how ColoWatch standardizes quality across partner imaging sites. They close on where AI could bring costs down and on finding purpose by helping others.
Dr. Mark Klein is the co-founder and president of ColoWatch. According to ColoWatch, he practiced as a board-certified diagnostic radiologist in the Washington, D.C., area for over 40 years and has performed over 8,000 CT colonography studies. He teaches radiologists to perform and read the exam for the American College of Radiology.
This episode is for general information and is not medical advice. Talk with your doctor about which colon cancer screening option is right for you.
Ideas to take with you
Six key takeaways
Screening should find polyps, not just cancer.
Most polyps are harmless, Dr. Klein says, but a small subset can turn into cancer. Removing those early prevents the cancer in the first place, so he judges a screening test by how well it finds polyps as well as cancers.
10:06 ↗A screening test is given to healthy people.
Because almost everyone who is screened is well, Dr. Klein argues that a screening test should carry as little risk as possible, and he sees virtual colonoscopy as a safe, accurate alternative.
13:51 ↗He calls colonoscopy a great test, and the right one for removing polyps.
Dr. Klein says colonoscopy is very accurate and very good at finding cancers and polyps. For first-line screening of healthy people, he explains why he sees virtual colonoscopy, with no sedation and a quick recovery, as a safe, accurate alternative.
15:31 ↗Stool and blood tests catch fewer polyps, in his view.
Dr. Klein says stool and blood tests miss most polyps, and that every positive result still leads to a colonoscopy. He calls them good but not good enough to prevent cancer.
18:22 ↗Quality depends on standardization.
The same prep, scan technique and software, read by radiologists trained for this exam, should make a virtual colonoscopy the same at any site, he says, like a drink at any Starbucks.
25:12 ↗Medicare covers it now.
Private insurers have covered screening CT colonography since the Affordable Care Act, Dr. Klein says, and Medicare added coverage in January 2025. Adults under 45 aren’t covered yet, so he hopes to reach them through wellness programs.
31:15 ↗
Find your thread
Episode chapters
Chapter times match the published YouTube episode. Each time opens that point on YouTube.
- 00:00 ↗
How President Obama skipped sedation
A preview: Dr. Klein tells how President Obama had a virtual colonoscopy without sedation, so he never had to hand over his powers.
- 00:33 ↗
Meet Dr. Mark Klein
Kevin introduces Dr. Klein, a radiologist who came out of retirement to co-found ColoWatch.
- 02:42 ↗
Virtual colonoscopy or CT colonography? Why the name matters
One test, two names: a journal editor’s choice that stuck, and why billing codes use “CT colonography.”
- 04:30 ↗
A radiology practice blocks from the White House
Decades of practice in central Washington, D.C., with a broad mix of patients.
- 05:17 ↗
The journal article that started it all
How a non-peer-reviewed “throwaway journal” first introduced him to virtual colonoscopy.
- 06:42 ↗
Boston, 1999: the first virtual colonoscopy symposium
The only attendee who wasn’t a full-time researcher, and his own early study with a local gastroenterology group.
- 08:29 ↗
Teaching radiologists for the American College of Radiology
About 18 years teaching radiologists from around the world how to perform and read the exam.
- 10:06 ↗
Finding polyps before they become cancer
Why colon cancer screening can prevent cancer, not just detect it.
- 12:07 ↗
Colon cancer is rising in adults under 50
The 2021 change that lowered the recommended screening age to 45, and the younger patients it still misses.
- 13:51 ↗
A screening test must be safe
Most people screened are healthy, so the test itself shouldn’t hurt them.
- 14:44 ↗
Why he came out of retirement
Why Dr. Klein chose to start a company instead of playing golf.
- 15:31 ↗
The risks of colonoscopy as a screening test
Dr. Klein calls colonoscopy a great test and explains why he believes a screening test for healthy people should carry as little risk as possible.
- 16:58 ↗
What a colonoscopy day costs patients
Prep, sedation, a ride home, and a lost day of work.
- 18:22 ↗
Stool tests and the follow-up cascade
How Dr. Klein sees positive stool DNA tests, and why every positive result leads to a colonoscopy.
- 20:26 ↗
FIT tests and the new blood tests
Why he considers tests that find a minority of polyps not good enough for prevention.
- 22:31 ↗
Polyp size and who needs a follow-up
Why small polyps can be left alone, and how many people he says need a colonoscopy after a virtual one.
- 24:30 ↗
The best-kept secret in American medicine
Why a test he calls accurate, safe and cost-effective is still little known.
- 25:12 ↗
Standardizing screening: the Starbucks analogy
Same prep, same scan technique, same software, specially trained readers.
- 27:42 ↗
Informed consent and offering alternatives
Why Dr. Klein thinks patients should hear about every screening option.
- 31:15 ↗
Insurance coverage and Medicare's 2025 decision
Private insurance coverage since the Affordable Care Act, and Medicare coverage from January 2025.
- 35:48 ↗
What the procedure is actually like
A low-volume prep, carbon dioxide instead of sedation, two eight-second scans, and about 15 minutes in the room.
- 37:54 ↗
Can capacity keep up with demand?
Busy radiologists, 15-minute reads, and looking at each colon ten times.
- 41:07 ↗
Findings outside the colon
How Dr. Klein found a tumor in his own kidney on his first virtual colonoscopy.
- 43:19 ↗
Building partner sites before the demand arrives
Partnering with hospitals and imaging centers, training their technologists, and reading studies remotely.
- 50:47 ↗
Screening adults under 45
Offering the test to younger adults through wellness programs and health savings accounts.
- 53:30 ↗
AI and bringing the cost down
Why Dr. Klein expects technology, including AI, to make the test far cheaper and more accessible.
- 57:59 ↗
When colonoscopy is the right test
Colonoscopy for removing polyps and for conditions such as inflammatory bowel disease, and choice for patients.
- 1:00:23 ↗
From selfish to selfless
Dr. Klein’s books and podcast on meaning and purpose.
- 1:01:35 ↗
Where to learn more about ColoWatch
ColoWatch’s website, for patients and providers.
The longer read
In-depth summary
One test, two names, and a symposium in Boston
The test has two names, Dr. Klein explains. Years ago, the editor of a major radiology journal decided to call it CT colonography. Dr. Klein wrote a letter arguing that nobody would know what that meant, while “virtual colonoscopy” at least tells people it is an alternative to colonoscopy. He lost the argument, and because billing codes use the formal term, both names are still in use. The episode uses them interchangeably.
He practiced radiology for decades a few blocks from the White House, and holds a faculty appointment at George Washington University Medical Center. He first read about virtual colonoscopy in a non-peer-reviewed review journal, then attended the first international symposium on the technique in Boston, which he recalls as October 1999. He was the only attendee who wasn’t a full-time researcher. He went on to run his own study of about 40 to 50 patients with a local gastroenterology group, scanning patients just before their colonoscopies and comparing results, and began offering the exam to patients in the early 2000s. He has taught the American College of Radiology’s course on it for about 18 years.
Why polyps matter and why safety comes first
Colon cancer affects men and women about equally, Dr. Klein says, and unlike most cancers it can be prevented through screening. Mammography looks for cancer; colon screening can also find polyps, the precursor lesions. Most polyps are irrelevant, but removing the small subset that can turn into cancer prevents the disease. He roughly estimates that finding polyps early could eliminate 80 to 90 percent of colon cancers, which is why he holds any screening test to finding polyps, not only cancer.
He says colon cancer rates are rising in adults under 50. The US Preventive Services Task Force lowered the recommended screening age from 50 to 45 in 2021, but by his figures more than half of the under-50 patients who get colon cancer are younger than 45. Screening younger, healthy people raises the stakes on safety. Because most people screened are healthy, Dr. Klein argues that a screening test should carry as little risk as possible. That conviction is why, after retiring from clinical practice, he co-founded ColoWatch instead of playing golf.
How Dr. Klein compares the screening options
Dr. Klein calls colonoscopy a great test: very accurate and very good at finding cancers and polyps. For screening healthy people, he believes the test should carry as little risk as possible, and he notes that, like any procedure involving sedation, colonoscopy isn’t risk-free. It also usually means sedation, a ride home and a lost day of work. He explains why he sees virtual colonoscopy as a safe, accurate alternative for first-line screening, with colonoscopy reserved for removing the polyps it finds.
He is more critical of stool and blood tests as preventive tools. Citing figures he gives from memory and from the manufacturer’s literature, he says a stool DNA test is positive for about 16 in 100 people, and that most of those positives turn out to be normal on the follow-up colonoscopy every one of them needs. In his view, FIT tests, stool DNA tests and the newer blood tests find only a minority of polyps, so they are “good, but not good enough.” He says virtual colonoscopy finds about 94 percent of the polyps that matter, and that serious complications have been very rare in his experience of about 8,000 exams, while noting that no medical test is completely free of risk.
Polyp size matters too, he says. Polyps smaller than about a centimeter carry very little cancer risk and grow slowly, so if only larger polyps are removed, he puts the share of people who need a colonoscopy after a virtual colonoscopy at about 6 to 10 percent. He also cites recent papers finding virtual colonoscopy the most cost-effective screening option.
The best-kept secret and the Starbucks analogy
If the test is this good, why haven’t most people heard of it? Dr. Klein says medicine tends to change all at once after reaching a critical mass. Gastroenterologists are comfortable with colonoscopy, and primary care providers, who decide which test a patient gets, trust their gastroenterologist colleagues. Patients also can’t easily judge how skilled a particular gastroenterologist is, because colonoscopy depends heavily on the operator.
Virtual colonoscopy, he argues, can be standardized: the same prep, the same scanning technique, the same software, and radiologists trained specifically to read it. He compares it to Starbucks, where a mocha tastes the same in Manhattan or Seattle, so you pick the closest store rather than the best one. He also points to informed consent: before a procedure, doctors are required to explain the alternatives, and he believes patients are rarely told about virtual colonoscopy. He tells the story of President Obama’s virtual colonoscopy at Bethesda Naval Hospital, done without sedation, so there was no need to transfer presidential powers.
Coverage, the procedure, and findings outside the colon
Under the Affordable Care Act, Dr. Klein explains, private insurers must cover screening tests recommended by the US Preventive Services Task Force, and screening CT colonography has had a billing code for private insurance since about 2010. Medicare added coverage in January 2025 (CMS finalized the change in its 2025 physician fee schedule). He describes visiting CMS years ago and believing that a single official held the decision up. He says insured patients now pay nothing out of pocket for screening, as with colonoscopy.
The exam itself starts with a low-volume prep the day before. At the imaging site, a small amount of carbon dioxide gently widens the colon, then the patient holds their breath for an eight-second scan lying on their back and another on each side. There is no sedation, patients spend about 15 minutes in the room, and they can go straight back to work. Because each study takes about 15 minutes to read, he says, and he reviews each colon about ten times, a shortage of trained radiologists limits capacity. He compares colonoscopy to looking through a hotel door’s peephole and virtual colonoscopy to opening the door.
Because the exam is a CT scan of the abdomen and pelvis, it can also find problems outside the colon. Dr. Klein found a tumor in his own kidney on his first virtual colonoscopy 13 years ago and had part of the kidney removed. He estimates that about one in 300 exams finds a cancer outside the colon, but stresses that ColoWatch doesn’t promote the test for that purpose.
Building ColoWatch, AI, and finding purpose
Kevin asks how ColoWatch prepares for demand that hasn’t arrived yet. Rather than buying its own scanners, Dr. Klein explains, ColoWatch partners with existing hospitals and imaging centers. He flies to each site to train the technologists, provides the prep, and connects the site to ColoWatch’s cloud, where studies are processed into 3D fly-through images and read remotely by radiologists ColoWatch has trained, with reports returned within 72 hours. He calls it a chicken-and-egg problem: sites want to see demand, and demand needs sites. He says no one could handle the volume if everyone switched tomorrow, and that his concern is quality variation between sites.
Kevin recalls the actor Chadwick Boseman, who died of colon cancer at the height of his career. Dr. Klein hopes ColoWatch can reach adults under 45, who aren’t covered by insurance yet, through employer wellness programs and health savings accounts. He expects technology, including AI, to bring costs down dramatically. He is clear that colonoscopy remains essential for removing polyps and for conditions such as inflammatory bowel disease, and that patients who prefer colonoscopy for screening should have one. They close on his books and podcast about meaning and purpose, which he sums up as moving from selfish to selfless.
In their words
Transcript excerpts
Selected passages from the episode, with filler words removed and punctuation lightly normalized. Bracketed words are added for clarity. Timestamps mark where each passage begins.
Prevention, not just detection
“Colon cancer, unlike other cancers, has an advantage in the sense that you can prevent the disease […]. I’m talking about finding the cancers before they become cancers. […] In colon cancer screening, we can find the precursor lesions for cancer. They’re called polyps.”
Safe for healthy people
“The problem is a screening test must not only be accurate for finding polyps and cancer, it must be safe. Because remember, most people who have any kind of screening test are going to be normal, right? […]”
A great test, not risk-free
“Now let me just say colonoscopy is a great test. It is very accurate, it’s very good at finding cancers, very good at finding polyps. […] But it has its problems. And the problem is it’s not just that it’s expensive, which it is, […] it’s not risk-free.”
The Starbucks analogy
“You go, I’m gonna meet my friend, we’re gonna go to Starbucks. You don’t say, ‘Hey, which is the best Starbucks in Manhattan?’ You say, ‘Which is the closest Starbucks in Manhattan,’ because a mocha is gonna taste the same at Starbucks A as B and C.”
Telling patients the alternatives
“In a sense, it’s a form of […] not malpractice, but poor practice, right? Because […] in all fairness to the primary care providers, they don’t know. They haven’t really been educated accurately.”
No sedation for the President
“So he went there, and they did a virtual colonoscopy on him, instead of putting him to sleep and having to transfer the superpowers of the presidency to the vice president for a day or at least a few hours.”
Eight seconds per scan
“We do one scan with you on your back. The scan itself takes about eight seconds. So you hold your breath for eight seconds. […] And then we turn you on each side and we do another same scan, another eight seconds, and you’re done. You’re off the table.”
Ten looks at every colon
“We can look at it today, tomorrow, next year, we can look at any time we want. I routinely look at a case ten times. Ten. So ten to one.”
The peephole and the open door
“If you go to an older hotel room and somebody knocks on the door, you can look through that little […] wide-angle thing to see who’s out there, right? […] That’s a colonoscopy. […] Or you can open the door and see who’s standing there. That’s a virtual colonoscopy.”
Give people a choice
“But for a screening test where most people are normal, it’s not the appropriate test. […] But I would say to people, look, if you don’t want to have a virtual colonoscopy, go have a colonoscopy. If that’s your choice, for whatever reason you choose that, go ahead.”
Selfish to selfless
“It’s not only the right thing to do, but it will give you the greatest joy in your life. There’s nothing [that] will give you greater joy than successfully helping somebody else. And you don’t have to be a doctor to do it.”
Keep exploring
Show notes & source links
People, organizations, programs, and further reading connected to the conversation. Each entry explains the connection. Links are references, not endorsements.
Dr. Mark Klein & ColoWatch
- ColoWatch ↗
The company Dr. Klein co-founded, which partners with imaging sites to offer standardized virtual colonoscopy. He recommends it as the starting point for patients and providers. ColoWatch is a Galang AI client.
1:01:35 ↗ - About ColoWatch · Dr. Mark Klein, co-founder and president ↗
ColoWatch’s team page: Dr. Klein practiced as a board-certified diagnostic radiologist in the Washington, D.C., area for over 40 years and has performed over 8,000 CT colonography studies.
00:33 ↗
The test & its coverage
- CT Colonography (Virtual Colonoscopy) · RadiologyInfo.org ↗
The patient guide from the American College of Radiology and the Radiological Society of North America: how the exam is prepared and performed, its benefits and its risks.
35:48 ↗ - CY 2025 Medicare Physician Fee Schedule Final Rule · CMS ↗
CMS’s November 2024 fact sheet. It expands Medicare colorectal cancer screening coverage to include CT colonography from 2025, the decision Dr. Klein discusses.
31:15 ↗ - Colorectal Cancer Screening Tests (NCD 210.3) · CMS ↗
Medicare’s national coverage determination listing which colorectal cancer screening tests it covers, and when.
31:15 ↗
Screening guidance
- Colorectal Cancer: Screening · US Preventive Services Task Force ↗
The 2021 recommendation that lowered the recommended starting age for screening from 50 to 45, and the screening options it covers, including CT colonography.
12:07 ↗ - Colorectal Cancer Screening Guideline · American Cancer Society ↗
The American Cancer Society’s screening recommendations for people at average and higher risk, including stool-based and visual exams such as CT colonography.
12:07 ↗ - Colorectal Cancer Screening (PDQ®) · National Cancer Institute ↗
NCI’s patient summary of colorectal cancer screening tests, including stool tests, colonoscopy and virtual colonoscopy, with their benefits and harms.
18:22 ↗
Accuracy & context
Editorial notes
- Disclosure. ColoWatch is a Galang AI client. Down To A Science is presented by Galang AI. The views expressed by guests are their own, and guest participation does not constitute endorsement of Galang AI or its products or services.
- Not medical advice. This episode is for general information and is not medical advice. Talk with your doctor about which colon cancer screening option is right for you. Links are references, not endorsements.
- Timestamps. Chapter times match the published YouTube episode. Excerpts at 15:34, 29:44, 37:07, 40:02 and 40:41 begin partway through a transcript line, so their times are approximate and may be a few seconds off.
- Claims and figures. Risk, accuracy and cost figures in the conversation are Dr. Klein’s own estimates and views, given from memory, and are not verified here. That includes the polyp detection rates he gives for stool, blood and CT tests and the share of exams with findings outside the colon. He describes his 80 to 90 percent prevention figure as a rough estimate. Medicare coverage of CT colonography from 2025 is confirmed against CMS’s fee schedule fact sheet; his account of why it took so long is his own.
- Stool and blood test figures. Figures Dr. Klein cites for stool and blood tests are his estimates. In published studies, roughly 3-6% of positive Cologuard results turn out to be cancer (see, for example, Imperiale et al., New England Journal of Medicine, 2014, PMID 24645800), many people with a positive result have polyps found at follow-up colonoscopy, and the U.S. Preventive Services Task Force and the American Cancer Society list stool tests among acceptable screening options.
- Left unnamed and unlinked. The radiology journal and its editor, the review journal where Dr. Klein first read about the test, the CMS official he describes, the radio host he mentions, and the books and podcast he has written are not named or linked, because they could not be confirmed from the conversation. The PubMed record for the 2014 Cologuard study is cited without a link because it blocked automated checks.
- Names and terminology. These notes use ColoWatch, CT colonography, gastroenterology, Chadwick Boseman, and Kevin G. Libuit where the automatic transcript contains phonetic spellings. Virtual colonoscopy and CT colonography are two names for the same exam, and these notes use them interchangeably, as the episode does.
Quick answers
About the episode & the show
- Who is Dr. Mark Klein?
- Dr. Mark Klein is the co-founder and president of ColoWatch. A board-certified diagnostic radiologist, he practiced in the Washington, D.C., area for over 40 years, has performed more than 8,000 virtual colonoscopies, and teaches radiologists to read them for the American College of Radiology. ColoWatch is a Galang AI client.
- What does Episode 9 cover?
- Episode 9 makes the case for virtual colonoscopy. Dr. Mark Klein and Kevin G. Libuit discuss why screening should find polyps, why Dr. Klein believes a screening test must be safe, how he compares colonoscopy, stool tests and blood tests, Medicare coverage, the procedure itself, findings outside the colon, and AI.
- What is a virtual colonoscopy?
- A virtual colonoscopy, also called CT colonography, is a low-dose CT scan of the colon, read by a trained radiologist, that screens for polyps and cancer. After a bowel prep, carbon dioxide gently widens the colon and two short scans are taken. Dr. Klein says no sedation is needed.
- Why does Dr. Klein prefer it to colonoscopy for screening?
- Dr. Klein calls colonoscopy a great test, but he believes a screening test for healthy people should carry as little risk as possible. He sees virtual colonoscopy as a safe, accurate alternative that finds polyps without sedation. He says people who prefer colonoscopy should still have one.
- Does Medicare cover virtual colonoscopy?
- Yes. CMS expanded Medicare colorectal cancer screening coverage to include CT colonography from 2025. Dr. Klein says private insurers have covered screening virtual colonoscopy since the Affordable Care Act, and that adults under 45 aren’t covered yet. Check your own plan, and talk with your doctor about which option suits you.
- Is this episode medical advice?
- No. This episode is for general information and is not medical advice. Talk with your doctor about which colon cancer screening option is right for you. Risk and accuracy figures in the conversation are Dr. Klein’s own estimates and views, and the editorial notes point to published sources where possible.
- Who hosts Down To A Science?
- Kevin G. Libuit hosts Down To A Science, a podcast of conversations with practitioners in science, technology, and business about their work, personal insights, and real-world impact. A scientist by training, Kevin is Chief Operating Officer at Galang AI, which presents the show. He previously led technology and operations at Theiagen Genomics.
- Where can I watch or listen to Episode 9?
- Watch Episode 9 of Down To A Science on YouTube, or listen on Spotify, Apple Podcasts, or Amazon Music. The episode runs just over an hour. The platform links at the top of this page open the episode directly, and the Show Notes index collects the guide for every episode.







